ADHD

For further information and guidance on how to treat your patients with Mellozzan^® (melatonin), please download and read the SPC

Mellozzan^® (melatonin) immediate-release tablets

Mellozzan^® is indicated for insomnia in children and adolescents aged 6-17 years with Attention-Deficit Hyperactivity Disorder (ADHD), where sleep hygiene measures have been insufficient.¹

Dosing & administration

• Recommended starting dose of Mellozzan^® tablets: 0.5–2 mg 30–60 minutes before bedtime¹
• The dose of melatonin can be increased by 1 mg every week until effect up to a maximum 5 mg per day, independent of age. The lowest effective dose should be sought¹
• The tablets can be crushed and mixed with water directly before the administration¹

Food can enhance the increase in plasma melatonin concentration (see section 5.2 of SPC). Intake of melatonin with carbohydrate-rich meals may impair blood glucose control for several hours (see section 4.4 of SPC). It is recommended that food is not consumed 2 hours before and 2 hours after intake of Mellozzan^® tablets, ideally at least 3 hours after a meal by persons with significantly impaired glucose tolerance or diabetes.¹

Safety and Monitoring

Access our full safety and monitoring information or please refer to section 4 of the SPC.